Search | Médecins Sans Frontières Access Campaign

2657 results found

Video |

26 May 2023

Access to Ebola treatments

Access to Ebola treatments with Julien Potet

Tags Tropical & neglected diseases Ebola World Health Assembly

Events |

24 May 2023

Event: Ensuring equity in pandemics: Lessons learnt from Ebola therapeutics R&D and access constraints

A discussion during WHA 2023 on pandemic preparedness and response, with access to Ebola treatments as an example

Tags Intellectual property and tradeTropical & neglected diseases Ebola

Report |

24 May 2023

Ensuring Access to New Treatments for Ebola Virus Disease

Despite their contributions to the R&D of new Ebola treatments, patients, treatment providers and endemic countries do not have reliable access

Tags Tropical & neglected diseases Ebola World Health Organization

Technical brief |

22 May 2023

Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?

The second in a series of roundtables focused on clinical trial cost transparency

Tags Research and development

Infographic

Three things to know about HIV/AIDS, 2022

Tags HIV/AIDS

Technical brief |

11 May 2023

Make It Count: Access to Point-of-Care CD4 Testing Under Threat

Global access to point-of-care CD4 devices and tests is under threat

Tags DiagnosticsHIV/AIDS World Health Organization

Clinician preparing samples for a point-of-care CD4 testing machine, Homa Bay County teaching and referral hospital, Kenya

Press release |

11 May 2023

Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production

MSF warned that access to point-of-care CD4 tests for HIV are under threat because Abbott and Becton Dickinson have decided to stop production

Tags DiagnosticsHIV/AIDS HIV/AIDS World Health Organization

Vials of liposomal amphotericin B (L-AmB)

Press release |

03 May 2023

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

Gilead hikes price while liposomal amphotericin B (L-AmB) for treatment of HIV-related cryptococcal meningitis remains unavailable and unaffordable in countries where it’s most needed

Tags HIV/AIDS cryptococcal meningitis liposomal amphotericin B Gilead

Video |

03 May 2023

Access challenges for HIV opportunistic infection drug L-AmB

MSF Access Campaign answers three questions on the challenges accessing liposomal amphotericin B (L-AmB), a key drug for treating the deadly HIV opportunistic infection cryptococcal meningitis.

Tags HIV/AIDS cryptococcal meningitis

A baby is vaccinated against measles and whooping cough by a member of MSF’s emergency team in Satema, in the south of Central African Republic

Blog |

28 April 2023

Injustice for a new generation of ‘zero-dose’ children

Every child who dies from a preventable disease is a failure of the system and an attack on the basic human rights of children everywhere

Bio lab at MSF’s Aden hospital in Yemen. The hospital focuses on treating and controlling antibiotic-resistant infections.

Press release |

26 April 2023

MSF responds to European Commission’s proposal to revise EU’s pharma legislation

MSF appreciates EC pharma legislation proposal to improve transparency by industry and the granting of compulsory licenses on medicines in the EU.

Tags Intellectual property and trade European Commission

Press release |

26 April 2023

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Access to TB drug bedaquiline, a backbone medicine for drug-resistant TB treatment regimens, remains out of reach for too many

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline Johnson & Johnson

Child receiving a vaccine through an MSF routine vaccination campaign, Wadi Khaled, Akkar, Lebanon, February 2022.

Press release |

20 April 2023

Gavi and donors must expand vaccine supply to catch up children up to age five

For World Immunization Week 2023, MSF calls on Gavi to expand its policy to catch up young children on missed vaccinations.

Tags Vaccines Gavi, the Vaccine Alliance

Technical brief |

07 April 2023

Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft

MSF’s recommendations on the WHO Pandemic Prevention, Preparedness and Response Accord zero draft

Tags Intellectual property and trade

About 4 in 10 people living with tuberculosis are not diagnosed or treated

Infographic

Three things to know about TB, April 2023

Tags Tuberculosis tuberculosis

Geralda Saint Victor, nurse at Pran Men’m clinic, Port-au-Prince, Haiti, responding to the sexual and gender-based violence (SGBV) hotline. The MSF clinic provides medical and psychosocial care, including prophylaxis for HIV.

Press release |

30 March 2023

Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug

With affordable generics likely years away, ViiV must make information public on supply of long-acting cabotegravir and global distribution plan to ensure access for people in high HIV burden low- and middle-income countries

Tags HIV/AIDS HIV/AIDS cabotegravir ViiV

MSF Doctor Joan providing a consultation to Nischaya, an XDR-TB patient, in the MSF clinic in Mumbai.

Press release |

23 March 2023

MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend monopoly on lifesaving TB drug

2019 patent challenge by TB survivors, Nandita Venkatesan and Phumeza Tisile, was successful against J&J's secondary patent application for bedaquiline.

Tags Tuberculosis tuberculosis bedaquiline Johnson & Johnson India

Bibi Amina and her granddaughter Sayeeda wait to see a doctor at MSF's DR-TB hospital in Kandahar, Afghanistan, September 2022

Press release |

22 March 2023

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

MSF called on governments and donors to speed up access to diagnostic tests, and shorter, safer and more effective treatments, for DR-TB.

Tags Tuberculosis drug-resistant TB GeneXpert World Health Organization

A pharmacist unpacks medications at the mobile clinic pharmacy. Through mobile clinics, MSF provides medical services to local populations.

Press release |

14 March 2023

News Update: EU-India FTA negotiations could have negative impact on access to medicines

MSF response to negotiations on an India-EU free trade agreement (FTA) regarding harmful intellectual property (IP) provisions

Tags Intellectual property and trade free trade agreement European CommissionEuropean Free Trade Association United KingdomIndiaEuropean Union

MSF collaborated with local NGOs to support vulnerable groups during the COVID Omicron wave, Hong Kong, March 2022.

Blog |

13 March 2023

Amid scarcity and soaring prices, China could issue compulsory license for Paxlovid

After three years of its “Zero COVID” policy, the Chinese government allowed a return to relative normalcy for its citizens in early December 2022. Due to the ongoing transmission of Omicron and its numerous COVID subvariants in China, the sudden policy shift was accompanied by rapid community transmission across the country and high numbers of severe COVID cases.

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Access to Ebola treatments

Event: Ensuring equity in pandemics: Lessons learnt from Ebola therapeutics R&D and access constraints

Ensuring Access to New Treatments for Ebola Virus Disease

Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?

Three things to know about HIV/AIDS, 2022

Make It Count: Access to Point-of-Care CD4 Testing Under Threat

Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

Access challenges for HIV opportunistic infection drug L-AmB

Injustice for a new generation of ‘zero-dose’ children

MSF responds to European Commission’s proposal to revise EU’s pharma legislation

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Gavi and donors must expand vaccine supply to catch up children up to age five

Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft

Three things to know about TB, April 2023

Pharmaceutical corporation ViiV must improve its failing access strategy for lifesaving HIV prevention drug

MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend monopoly on lifesaving TB drug

Urgent need to improve access to TB testing to support rollout of better, safer, shorter treatment for drug-resistant TB

News Update: EU-India FTA negotiations could have negative impact on access to medicines

Amid scarcity and soaring prices, China could issue compulsory license for Paxlovid